Who is sponsoring NCT05129228?

NCT05129228 is sponsored by St. Francis Hospital, New York.

What drugs are being tested in NCT05129228?

Interventions in NCT05129228: OCT-guided saphenous vein CABG.

What condition does NCT05129228 study?

NCT05129228 studies Coronary Bypass Graft Stenosis.

Is NCT05129228 still recruiting?

NCT05129228 is currently status unknown. Last updated 5 May 2022.

Last reviewed 2022-05-05 · How we verify

NCT05129228: OCTOCAB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optical Coherence Tomography of the Saphenous Vein Graft

Status unknown NA Last updated 5 May 2022

What this trial tests

NA trial testing OCT-guided saphenous vein CABG in Coronary Bypass Graft Stenosis in 760 participants. Status unknown.

Timeline

4 April 2022

Primary endpoint
4 April 2024

4 April 2026

Quick facts

Lead sponsor	St. Francis Hospital, New York
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	760
Start date	4 April 2022
Primary completion	4 April 2024
Estimated completion	4 April 2026
Sites	1 location across United States

Drugs / interventions tested

OCT-guided saphenous vein CABG

Conditions studied

Coronary Bypass Graft Stenosis — all drugs for Coronary Bypass Graft Stenosis →

Sponsor

St. Francis Hospital, New York

Who can join

18 and older, any sex, with Coronary Bypass Graft Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other St. Francis Hospital, New York trials

Trials by the same sponsor.

NCT07195903 — The STAND-UP Study · NA · recruiting
NCT04621461 — Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting · Phase 4 · completed
NCT04370782 — Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting · Phase 4 · completed
NCT03106961 — OCT and Scaffold Embedding After NC Balloon · unknown
NCT03581032 — Optimization of Cardiac Pacing Using CardioMEMS · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05129228 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Francis Hospital, New York
Last refreshed: 5 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05129228.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing